Maturation of the developing human fetal prostate in a rodent xenograft model

Prostate

Volumn 73, Issue 16, 2013, Pages 1761-1775

  Saffarini, Camelia M ^a   McDonnell, Elizabeth V ^a   Amin, Ali ^a,b   Spade, Daniel J ^a   Huse, Susan M ^a   Kostadinov, Stefan ^a,c   Hall, Susan J ^a   Boekelheide, Kim ^a  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

DNA methylation; human fetal prostate; immunohistochemistry; xenotransplantation

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANDROGEN RECEPTOR; CALDESMON; CYTOKERATIN 18; DNA; ESTROGEN RECEPTOR ALPHA; KI 67 ANTIGEN; PROSTATE SPECIFIC ANTIGEN; PROTEIN P63; VIMENTIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPITHELIUM; FETUS; FETUS DEVELOPMENT; GENE CLUSTER; GENE EXPRESSION; GENETIC ANALYSIS; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMPLANT; LASER CAPTURE MICRODISSECTION; MALE; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROSTATE DEVELOPMENT; RAT; STRESS; STROMA CELL; TISSUE DIFFERENTIATION; TISSUE SECTION; XENOGRAFT;

DNA METHYLATION; HUMAN FETAL PROSTATE; IMMUNOHISTOCHEMISTRY; XENOTRANSPLANTATION;

ANIMALS; CPG ISLANDS; DNA METHYLATION; FETAL DEVELOPMENT; HETEROGRAFTS; HUMANS; MALE; MODELS, ANIMAL; PROSTATE; RATS; RATS, NUDE;

EID: 84886949248     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22713     Document Type: Article

References (72)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ,. Cancer statistics, 2008. CA Cancer J Clin 2008; 58 (2): 71-96.
2. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2012. CA Cancer J Clin 2012; 62 (1): 10-29.
3. Hsing AW, Tsao L, Devesa SS,. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000; 85 (1): 60-67.
4. Gann PH,. Risk factors for prostate cancer. Rev Urol 2002; 4 (Suppl 5): S3-S10.
5. Yonemura CY, Cunha GR, Sugimura Y, Mee SL,. Temporal and spatial factors in diethylstilbestrol-induced squamous metaplasia in the developing human prostate. II. Persistent changes after removal of diethylstilbestrol. Acta Anat 1995; 153 (1): 1-11.
6. Sugimura Y, Cunha GR, Yonemura CU, Kawamura J,. Temporal and spatial factors in diethylstilbestrol-induced squamous metaplasia of the developing human prostate. Hum Pathol 1988; 19 (2): 133-139.
7. Andrews GS,. The histology of the human foetal and prepubertal prostates. J Anat 1951; 85 (1): 44-54.
8. Adams JY, Leav I, Lau KM, Ho SM, Pflueger SM,. Expression of estrogen receptor beta in the fetal, neonatal, and prepubertal human prostate. Prostate 2002; 52 (1): 69-81.
9. Marcus R, Korenman SG,. Estrogens and the human male. Annu Rev Med 1976; 27: 357-370.
10. McPherson SJ, Ellem SJ, Risbridger GP,. Estrogen-regulated development and differentiation of the prostate. Differentiation 2008; 76 (6): 660-670.
11. Cunha GR, Alarid ET, Turner T, Donjacour AA, Boutin EL, Foster BA,. Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors. J Androl 1992; 13 (6): 465-475.
12. Harmelin A, Danon T, Kela I, Brenner O,. Biopsy of the mouse prostate. Lab Anim 2005; 39 (2): 215-220.
13. McNeal JE,. Normal histology of the prostate. Am J Surg Pathol 1988; 12 (8): 619-633.
14. Coffey DS, Isaacs JT,. Requirements for an idealized animal model of prostatic cancer. Prog Clin Biol Res 1980; 37: 379-391.
15. Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, Rubin MA, Humphrey PA, Sundberg JP, Rozengurt N, Barrios R, Ward JM, Cardiff RD,. Prostate pathology of genetically engineered mice: Definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 2004; 64 (6): 2270-2305.
16. Xia T, Blackburn WR, Gardner WA Jr., Fetal prostate growth and development. Pediatr Pathol 1990; 10 (4): 527-537.
17. Kellokumpu-Lehtinen P, Santti R, Pelliniemi LJ,. Correlation of early cytodifferentiation of the human fetal prostate and Leydig cells. Anat Rec 1980; 196 (3): 263-273.
18. Cunha GR,. Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer 1994; 74 (3 Suppl): 1030-1044.
19. Hayward SW, Cunha GR, Dahiya R,. Normal development and carcinogenesis of the prostate. A unifying hypothesis. Ann N Y Acad Sci 1996; 784: 50-62.
20. De Paepe ME, Chu S, Heger N, Hall S, Mao Q,. Resilience of the human fetal lung following stillbirth: Potential relevance for pulmonary regenerative medicine. Exp Lung Res 2012; 38 (1): 43-54.
21. Szot GL, Koudria P, Bluestone JA,. Transplantation of pancreatic islets into the kidney capsule of diabetic mice. J Vis Exp 2007; (9): 404.
22. Wang Y, Revelo MP, Sudilovsky D, Cao M, Chen WG, Goetz L, Xue H, Sadar M, Shappell SB, Cunha GR, Hayward SW,. Development and characterization of efficient xenograft models for benign and malignant human prostate tissue. Prostate 2005; 64 (2): 149-159.
23. Wang Y, Xue H, Cutz JC, Bayani J, Mawji NR, Chen WG, Goetz LJ, Hayward SW, Sadar MD, Gilks CB, Gout PW, Squire JA, Cunha GR, Wang YZ,. An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line. Lab Invest 2005; 85 (11): 1392-1404.
24. Espina V, Wulfkuhle JD, Calvert VS, VanMeter A, Zhou W, Coukos G, Geho DH, Petricoin EF III, Liotta LA,. Laser-capture microdissection. Nat Protoc 2006; 1 (2): 586-603.
25. Maksimovic J, Gordon L, Oshlack A,. SWAN: Subset-quantile within array normalization for illumina infinium HumanMethylation450 BeadChips. Genome Biol 2012; 13 (6): R44.
26. Hansen KD, Aryee M,. minfi: Analyze Illumina's 450K methylation arrays. R package version 1.4.0.
27. Wang D, Yan L, Hu Q, Sucheston LE, Higgins MJ, Ambrosone CB, Johnson CS, Smiraglia DJ, Liu S,. IMA: An R package for high-throughput analysis of Illumina's 450 K Infinium methylation data. Bioinformatics 2012; 28 (5): 729-730.
28. de Hoon MJ, Imoto S, Nolan J, Miyano S,. Open source clustering software. Bioinformatics 2004; 20 (9): 1453-1454.
29. Saldanha AJ,. Java Treeview-Extensible visualization of microarray data. Bioinformatics 2004; 20 (17): 3246-3248.
30. Huang daW, Sherman BT, Lempicki RA,. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4 (1): 44-57.
31. Huang daW, Sherman BT, Lempicki RA,. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009; 37 (1): 1-13.
32. Bennett JA, Pilon VA, MacDowell RT,. Evaluation of growth and histology of human tumor xenografts implanted under the renal capsule of immunocompetent and immunodeficient mice. Cancer Res 1985; 45 (10): 4963-4969.
33. Morton CL, Houghton PJ,. Establishment of human tumor xenografts in immunodeficient mice. Nat Protoc 2007; 2 (2): 247-250.
34. Priolo C, Agostini M, Vena N, Ligon AH, Fiorentino M, Shin E, Farsetti A, Pontecorvi A, Sicinska E, Loda M,. Establishment and genomic characterization of mouse xenografts of human primary prostate tumors. Am J Pathol 2010; 176 (4): 1901-1913.
35. Zhou H, Sun HB, Huang WB, Xu Z, Su JH, Zhu JG, Jia RP, Liu J,. [Phenotypic differences of stroma cells in benign and malignant human prostate tissues]. Zhonghua Yi Xue Za Zhi 2012; 92 (8): 516-519.
36. Xin L, Ide H, Kim Y, Dubey P, Witte ON,. In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme. Proc Natl Acad Sci USA 2003; 100 (Suppl 1): 11896-11903.
37. Kurita T, Medina RT, Mills AA, Cunha GR,. Role of p63 and basal cells in the prostate. Development 2004; 131 (20): 4955-4964.
38. Letellier G, Perez MJ, Yacoub M, Levillain P, Cussenot O, Fromont G,. Epithelial phenotypes in the developing human prostate. J Histochem Cytochem 2007; 55 (9): 885-890.
39. Hayward SW, Baskin LS, Haughney PC, Cunha AR, Foster BA, Dahiya R, Prins GS, Cunha GR,. Epithelial development in the rat ventral prostate, anterior prostate and seminal vesicle. Acta Anat (Basel) 1996; 155 (2): 81-93.
40. Soeffing WJ, Timms BG,. Localization of androgen receptor and cell-specific cytokeratins in basal cells of rat ventral prostate. J Androl 1995; 16 (3): 197-208.
41. Ud Din N, Qureshi A, Mansoor S,. Utility of p63 immunohistochemical stain in differentiating urothelial carcinomas from adenocarcinomas of prostate. Indian J Pathol Microbiol 2011; 54 (1): 59-62.
42. Grisanzio C, Signoretti S,. p63 in prostate biology and pathology. J Cell Biochem 2008; 103 (5): 1354-1368.
43. Shapiro E, Huang H, McFadden DE, Masch RJ, Ng E, Lepor H, Wu XR,. The prostatic utricle is not a Mullerian duct remnant: Immunohistochemical evidence for a distinct urogenital sinus origin. J Urol 2004; 172 (4 Pt. 2): 1753-1756, discussion 1756.
44. Trompetter M, Smedts F, van der Wijk J, Schoots C, de Jong HJ, Hopman A, de la Rosette J,. Keratin profiling in the developing human prostate. A different approach to understanding epithelial lineage. Anticancer Res 2008; 28 (1A): 237-243.
45. Farnsworth WE,. Prostate stroma: Physiology. Prostate 1999; 38 (1): 60-72.
46. Bierhoff E, Walljasper U, Hofmann D, Vogel J, Wernert N, Pfeifer U,. Morphological analogies of fetal prostate stroma and stromal nodules in BPH. Prostate 1997; 31 (4): 234-240.
47. Lowsley OS,. The prostate gland in old age. Ann Surg 1915; 62 (6): 716-737.
48. Walther S, Strittmatter F, Roosen A, Heinzer F, Rutz B, Stief CG, Gratzke C, Hennenberg M,. Expression and alpha1-adrenoceptor regulation of caldesmon in human prostate smooth muscle. Urology 2012; 79 (3): 745.e5-745.e12.
49. Makarewicz R, Zyromska A, Andrusewicz H,. Comparative analysis of biological profiles of benign prostate hyperplasia and prostate cancer as potential diagnostic, prognostic and predictive indicators. Folia Histochem Cytobiol 2011; 49 (3): 452-457.
50. Wang W, Bergh A, Damber JE,. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate. Prostate 2009; 69 (13): 1378-1386.
51. Tomaszewski JJ, Cummings JL, Parwani AV, Dhir R, Mason JB, Nelson JB, Bacich DJ, O'Keefe DS,. Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate. Prostate 2011; 71 (12): 1287-1293.
52. Nash AF, Melezinek I,. The role of prostate specific antigen measurement in the detection and management of prostate cancer. Endocr Relat Cancer 2000; 7 (1): 37-51.
53. Sikaris K,. Prostate cancer screening. Pathology 2012; 44 (2): 99-109.
54. Wernert N, Kern L, Heitz P, Bonkhoff H, Goebbels R, Seitz G, Inniger R, Remberger K, Dhom G,. Morphological and immunohistochemical investigations of the utriculus prostaticus from the fetal period up to adulthood. Prostate 1990; 17 (1): 19-30.
55. Nicholson TM, Ricke WA,. Androgens and estrogens in benign prostatic hyperplasia: Past, present and future. Differentiation 2011; 82 (4-5): 184-199.
56. Taneja SS, Ha S, Swenson NK, Torra IP, Rome S, Walden PD, Huang HY, Shapiro E, Garabedian MJ, Logan SK,. ART-27, an androgen receptor coactivator regulated in prostate development and cancer. J Biol Chem 2004; 279 (14): 13944-13952.
57. Hamilton-Reeves JM, Rebello SA, Thomas W, Slaton JW, Kurzer MS,. Isoflavone-rich soy protein isolate suppresses androgen receptor expression without altering estrogen receptor-beta expression or serum hormonal profiles in men at high risk of prostate cancer. J Nutr 2007; 137 (7): 1769-1775.
58. Chen M, Hsu I, Wolfe A, Radovick S, Huang K, Yu S, Chang C, Messing EM, Yeh S,. Defects of prostate development and reproductive system in the estrogen receptor-alpha null male mice. Endocrinology 2009; 150 (1): 251-259.
59. Majumder PK, Kumar VL,. Androgen receptor mRNA detection in the human foetal prostate. Int Urol Nephrol 1997; 29 (6): 633-635.
60. Shapiro E, Huang H, Masch RJ, McFadden DE, Wilson EL, Wu XR,. Immunolocalization of estrogen receptor alpha and beta in human fetal prostate. J Urol 2005; 174 (5): 2051-2053.
61. Aumuller G, Holterhus PM, Konrad L, von Rahden B, Hiort O, Esquenet M, Verhoeven G,. Immunohistochemistry and in situ hybridization of the androgen receptor in the developing human prostate. Anat Embryol 1998; 197 (3): 199-208.
62. Cai G, Huang H, Shapiro E, Zhou H, Yeh S, Melamed J, Greco MA, Lee P,. Expression of androgen receptor associated protein 55 (ARA55) in the developing human fetal prostate. J Urol 2005; 173 (6): 2190-2193.
63. Li LC, Okino ST, Dahiya R,. DNA methylation in prostate cancer. Biochim Biophys Acta 2004; 1704 (2): 87-102.
64. Edwards TM, Myers JP,. Environmental exposures and gene regulation in disease etiology. Environ Health Perspect 2007; 115 (9): 1264-1270.
65. Ricke EA, Williams K, Lee YF, Couto S, Wang Y, Hayward SW, Cunha GR, Ricke WA,. Androgen hormone action in prostatic carcinogenesis: Stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis. Carcinogenesis 2012; 33 (7): 1391-1398.
66. Kim JW, Kim ST, Turner AR, Young T, Smith S, Liu W, Lindberg J, Egevad L, Gronberg H, Isaacs WB, Xu J,. Identification of new differentially methylated genes that have potential functional consequences in prostate cancer. PLoS ONE 2012; 7 (10): e48455.
67. Kron K, Pethe V, Briollais L, Sadikovic B, Ozcelik H, Sunderji A, Venkateswaran V, Pinthus J, Fleshner N, van der Kwast T, Bapat B,. Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays. PLoS ONE 2009; 4 (3): e4830.
68. Li LC, Carroll PR, Dahiya R,. Epigenetic changes in prostate cancer: Implication for diagnosis and treatment. J Natl Cancer Inst 2005; 97 (2): 103-115.
69. Phe V, Cussenot O, Roupret M,. Methylated genes as potential biomarkers in prostate cancer. BJU Int 2010; 105 (10): 1364-1370.
70. Goldstein AS, Drake JM, Burnes DL, Finley DS, Zhang H, Reiter RE, Huang J, Witte ON,. Purification and direct transformation of epithelial progenitor cells from primary human prostate. Nat Protoc 2011; 6 (5): 656-667.
71. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON,. Identification of a cell of origin for human prostate cancer. Science 2010; 329 (5991): 568-571.
72. Hayward SW, Rosen MA, Cunha GR,. Stromal-epithelial interactions in the normal and neoplastic prostate. Br J Urol 1997; 79 (Suppl 2): 18-26.